Health China

Garnet Bio gains $10.4M for cell-based therapies

Safeguard Scientifics says it joined a group of investors who ponied up $10.4 million to finance the development work underway at Garnet Biotherapeutics. Other investors include Alliance Technology Ventures and SCP Vitalife Partners, which led the round.


Biotech China 2014
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.